These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17261116)

  • 21. Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.
    Jones E; Pike J; Marshall T; Ye X
    BMC Health Serv Res; 2016 Jul; 16():294. PubMed ID: 27443278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
    Karampampa K; Gustavsson A; Miltenburger C; Eckert B
    Mult Scler; 2012 Jun; 18(2 Suppl):7-15. PubMed ID: 22623122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
    Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
    Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.
    Karampampa K; Gustavsson A; Miltenburger C; Kindundu CM; Selchen DH
    J Popul Ther Clin Pharmacol; 2012; 19(1):e11-25. PubMed ID: 22247419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature.
    Naci H; Fleurence R; Birt J; Duhig A
    J Med Econ; 2010 Mar; 13(1):78-89. PubMed ID: 20047364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
    Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
    J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire.
    Bonniaud V; Parratte B; Amarenco G; Jackowski D; Didier JP; Guyatt G
    Arch Phys Med Rehabil; 2004 Aug; 85(8):1317-23. PubMed ID: 15295759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost and health related quality of life consequences of multiple sclerosis.
    Grima DT; Torrance GW; Francis G; Rice G; Rosner AJ; Lafortune L
    Mult Scler; 2000 Apr; 6(2):91-8. PubMed ID: 10773854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into the burden and costs of multiple sclerosis in Europe: Results for the United Kingdom.
    Thompson A; Kobelt G; Berg J; Capsa D; Eriksson J; Miller D;
    Mult Scler; 2017 Aug; 23(2_suppl):204-216. PubMed ID: 28643587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life and utilities among Lebanese patients with Multiple Sclerosis: A cross-sectional study.
    Dahham J; Hiligsmann M; Kremer I; Khoury SJ; Darwish H; Hosseini H; Hallit S; Evers S; Rizk R
    Mult Scler Relat Disord; 2024 Jun; 86():105635. PubMed ID: 38640585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Societal costs of multiple sclerosis in Ireland.
    Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K
    J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-assessed health status changes in a community cohort of people with multiple sclerosis: 11 years of follow-up.
    Giordano A; Ferrari G; Radice D; Randi G; Bisanti L; Solari A;
    Eur J Neurol; 2013 Apr; 20(4):681-8. PubMed ID: 23217086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study.
    Wu N; Minden SL; Hoaglin DC; Hadden L; Frankel D
    J Health Hum Serv Adm; 2007; 30(3):233-67. PubMed ID: 18236703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study.
    Trigg R; Jones RW; Knapp M; King D; Lacey LA;
    Int J Geriatr Psychiatry; 2015 Apr; 30(4):400-8. PubMed ID: 24920081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What drives quality of life in multiple sclerosis?
    Hemmett L; Holmes J; Barnes M; Russell N
    QJM; 2004 Oct; 97(10):671-6. PubMed ID: 15367738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic costs associated with an MS relapse.
    O'Connell K; Kelly SB; Fogarty E; Duggan M; Buckley L; Hutchinson M; McGuigan C; Tubridy N
    Mult Scler Relat Disord; 2014 Nov; 3(6):678-83. PubMed ID: 25891546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of an individual's evaluation of functional status for health-related quality of life in patients with multiple sclerosis.
    Gavelova M; Nagyova I; Rosenberger J; Krokavcova M; Gdovinova Z; Groothoff JW; van Dijk JP
    Disabil Health J; 2015 Jul; 8(3):372-9. PubMed ID: 25981341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in disability in people with multiple sclerosis: a 10-year prospective study.
    Conradsson D; Ytterberg C; von Koch L; Johansson S
    J Neurol; 2018 Jan; 265(1):119-126. PubMed ID: 29159465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Turkey.
    Karabudak R; Karampampa K; Calışkan Z;
    J Med Econ; 2015 Jan; 18(1):69-75. PubMed ID: 25116693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.